NSCLC | SCLC | |
Subjects | 204 | 74 |
Number of cycles median (range) | 3 (1–22) | 3 (1–6) |
Response | ||
CR | 0 | 1 |
PR | 15 | 18 |
SD | 68 | 17 |
PD | 83 | 23 |
NE | 38 | 15 |
Overall response rate n | 15 | 19 |
% (95% CI) | 7.4 (3.8–10.9) | 25.7 (15.7–38.8) |
Disease control rate n | 83 | 36 |
% (95% CI) | 40.7 (33.9–49.6) | 48.6 (34.6–60.9) |
Introduction rate of third-line chemotherapy | 46.6% | 44.6% |
NSCLC: nonsmall cell lung cancer; SCLC: small cell lung cancer; CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; NE: not evaluated.